SC 13D Filing

Company

LIGAND PHARMACEUTICALS INC

Filed

April 15, 1997

Accession Number

0001012168-97-000014

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →